Luciana Madeira holds a degree in Chemistry with Technological Attribution from the Federal University of Rio de Janeiro. She earned her doctorate in Technology of Biochemical Processes and her master’s degree in Biochemistry from the same institution. She has a postdoctoral fellowship in Molecular Microbiology and Biotechnology at the Drug Research Institute of the University of Lisbon, Portugal, focusing on monoclonal antibodies conjugated to drugs. She has experience in mass spectrometry, with an emphasis on the development of analytical methodologies using LC/MS-MS for the analysis of drugs and residues. She works as a Technologist in Public Health at Fiocruz, having contributed to the development of bacterial vaccines, including the production of the vaccine against Haemophilus influenzae B, and in coordinating a Technological Innovation Center. Currently, she is a researcher at the Laboratory of Physical-Chemical Analytical Technologies of Bio-Manguinhos/Fiocruz, where she leads projects focused on the structural characterization of proteins, with particular emphasis on monoclonal antibodies, utilizing advanced mass spectrometry techniques.